{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T15:57:32Z","timestamp":1785427052433,"version":"3.56.0"},"reference-count":117,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01AG050518"],"award-info":[{"award-number":["R01AG050518"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain Research"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.brainres.2018.08.024","type":"journal-article","created":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T03:00:31Z","timestamp":1535079631000},"page":"145921","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"C","title":["Intranasal administration of orexin peptides: Mechanisms and therapeutic potential for age-related cognitive dysfunction"],"prefix":"10.1016","volume":"1731","author":[{"given":"Coleman B.","family":"Calva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim R.","family":"Fadel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.brainres.2018.08.024_b0005","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1124\/jpet.102.048025","article-title":"Distinct recognition of OX1 and OX2 receptors by orexin peptides","volume":"305","author":"Ammoun","year":"2003","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2018.08.024_b0010","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/S0960-894X(02)00851-X","article-title":"Development of an orexin-2 receptor selective agonist, [Ala11, D-Leu15]orexin-B","volume":"13","author":"Asahi","year":"2003","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.brainres.2018.08.024_b0015","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1002\/hbm.23510","article-title":"Convergent gustatory and viscerosensory processing in the human dorsal mid-insula","volume":"38","author":"Avery","year":"2017","journal-title":"Hum. Brain Mapp."},{"key":"10.1016\/j.brainres.2018.08.024_b0020","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1093\/brain\/awn193","article-title":"Olfactory dysfunction in patients with narcolepsy with cataplexy is restored by intranasal Orexin A (Hypocretin-1)","volume":"131","author":"Baier","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2018.08.024_b0025","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.sleep.2011.06.015","article-title":"Effects of intranasal hypocretin-1 (orexin A) on sleep in narcolepsy with cataplexy","volume":"12","author":"Baier","year":"2011","journal-title":"Sleep Med."},{"key":"10.1016\/j.brainres.2018.08.024_b0030","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/7854_2016_44","article-title":"Hypocretin\/orexin and plastic adaptations associated with drug abuse","volume":"33","author":"Baimel","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.brainres.2018.08.024_b0035","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/cne.10783","article-title":"Overlapping distributions of orexin\/hypocretin- and dopamine-beta-hydroxylase immunoreactive fibers in rat brain regions mediating arousal, motivation, and stress","volume":"464","author":"Baldo","year":"2003","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.brainres.2018.08.024_b0040","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.sleep.2010.07.004","article-title":"Olfactory dysfunction in narcolepsy with cataplexy","volume":"11","author":"Bayard","year":"2010","journal-title":"Sleep Med."},{"key":"10.1016\/j.brainres.2018.08.024_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.tins.2013.04.005","article-title":"Neurons and circuits for odor processing in the piriform cortex","author":"Bekkers","year":"2013","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.brainres.2018.08.024_b0050","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/j.neuron.2006.01.016","article-title":"Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine","volume":"49","author":"Borgland","year":"2006","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2018.08.024_b0055","article-title":"Increased acetylcholine and glutamate efflux in the prefrontal cortex following intranasal orexin-A (hypocretin-1)","author":"Calva","year":"2017","journal-title":"J. Neurochem."},{"key":"10.1016\/j.brainres.2018.08.024_b0060","article-title":"Orexin system: the key for a healthy life","author":"Chieffi","year":"2017","journal-title":"Front. Neurol."},{"key":"10.1016\/j.brainres.2018.08.024_b0065","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1038\/nrn894","article-title":"How do you feel? Interoception: the sense of the physiological condition of the body","volume":"3","author":"Craig","year":"2002","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.brainres.2018.08.024_b0070","doi-asserted-by":"crossref","first-page":"12584","DOI":"10.1038\/srep12584","article-title":"Orexin receptors exert a neuroprotective effect in Alzheimer\u2019s disease (AD) via heterodimerization with GPR103","volume":"5","author":"Davies","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.brainres.2018.08.024_b0075","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1073\/pnas.95.1.322","article-title":"The hypocretins: hypothalamus-specific peptides with neuroexcitatory activity","volume":"95","author":"de Lecea","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.brainres.2018.08.024_b0080","doi-asserted-by":"crossref","first-page":"14239","DOI":"10.1523\/JNEUROSCI.3878-07.2007","article-title":"Systemic and nasal delivery of orexin-A (Hypocretin-1) reduces the effects of sleep deprivation on cognitive performance in nonhuman primates","volume":"27","author":"Deadwyler","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2018.08.024_b0085","doi-asserted-by":"crossref","DOI":"10.1002\/jps.21604","article-title":"Intranasal drug targeting of hypocretin-1 (orexin-A) to the central nervous system","author":"Dhuria","year":"2009","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.brainres.2018.08.024_b0090","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1002\/jps.21924","article-title":"Intranasal delivery to the central nervous system: mechanisms and experimental considerations","volume":"99","author":"Dhuria","year":"2010","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.brainres.2018.08.024_b0095","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.neulet.2016.05.053","article-title":"Food consumption and activity levels increase in rats following intranasal Hypocretin-1","volume":"627","author":"Dhuria","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2018.08.024_b0100","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.neurobiolaging.2006.11.014","article-title":"Olfaction in patients with mild cognitive impairment and Alzheimer\u2019s disease","volume":"29","author":"Djordjevic","year":"2008","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2018.08.024_b0105","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1097\/00000542-200605000-00019","article-title":"Orexins increase cortical acetylcholine release and electroencephalographic activation through orexin-1 receptor in the rat basal forebrain during isoflurane anesthesia","volume":"104","author":"Dong","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1016\/j.brainres.2018.08.024_b0110","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.neurobiolaging.2006.05.025","article-title":"Orexin neuronal changes in the locus coeruleus of the aging rhesus macaque","volume":"28","author":"Downs","year":"2007","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2018.08.024_b0115","doi-asserted-by":"crossref","first-page":"8354","DOI":"10.1523\/JNEUROSCI.2751-04.2004","article-title":"Aging results in reduced epidermal growth factor receptor signaling, diminished olfactory neurogenesis, and deficits in fine olfactory discrimination","volume":"24","author":"Enwere","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2018.08.024_b0120","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/cne.20369","article-title":"Organization of hypocretin\/orexin efferents to locus coeruleus and basal forebrain arousal-related structures","volume":"481","author":"Espa\u00f1a","year":"2005","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.brainres.2018.08.024_b0125","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.brainres.2009.08.046","article-title":"Orexin\/hypocretin modulation of the basal forebrain cholinergic system: role in attention","volume":"1314","author":"Fadel","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.brainres.2018.08.024_b0130","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/S0306-4522(02)00017-9","article-title":"Anatomical substrates of orexin-dopamine interactions: Lateral hypothalamic projections to the ventral tegmental area","volume":"111","author":"Fadel","year":"2002","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2018.08.024_b0135","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.neuroscience.2004.09.050","article-title":"Stimulation of cortical acetylcholine release by orexin A","volume":"130","author":"Fadel","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2018.08.024_b0140","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.neuroscience.2007.07.061","article-title":"Food-elicited increases in cortical acetylcholine release require orexin transmission","volume":"149","author":"Frederick-Duus","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2018.08.024_b0145","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1073\/pnas.89.2.738","article-title":"gamma-Aminobutyric acid-containing basal forebrain neurons innervate inhibitory interneurons in the neocortex","volume":"89","author":"Freund","year":"1992","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.brainres.2018.08.024_b0150","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/j.neurobiolaging.2011.03.014","article-title":"Hypocretin (orexin) loss in Alzheimer\u2019s disease","volume":"33","author":"Fronczek","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2018.08.024_b0155","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1093\/sleep\/26.8.953","article-title":"Effects of IV and ICV hypocretin-1 (orexin A) in hypocretin receptor-2 gene mutated narcoleptic dogs and IV hypocretin-1 replacement therapy in a hypocretin-ligand-deficient narcoleptic dog","volume":"26","author":"Fujiki","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.brainres.2018.08.024_b0160","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/B978-0-444-59489-1.00010-0","article-title":"Orexin receptors as therapeutic drug targets","volume":"198","author":"Gotter","year":"2012","journal-title":"Prog. Brain Res."},{"key":"10.1016\/j.brainres.2018.08.024_b0165","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1073\/pnas.86.5.1698","article-title":"Stimulus-specific neuronal oscillations in orientation columns of cat visual cortex","volume":"86","author":"Gray","year":"1989","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.brainres.2018.08.024_b0170","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/cne.10505","article-title":"Parvalbumin, calbindin, or calretinin in cortically projecting and GABAergic, cholinergic, or glutamatergic basal forebrain neurons of the rat","volume":"458","author":"Gritti","year":"2003","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.brainres.2018.08.024_b0175","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.neuroscience.2017.03.021","article-title":"Upregulation of orexin\/hypocretin expression in aged rats: Effects on feeding latency and neurotransmission in the insular cortex","volume":"350","author":"Hagar","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2018.08.024_b0180","doi-asserted-by":"crossref","DOI":"10.1124\/mi.8.3.5","article-title":"Revealing the potential of intranasally administered orexin A","author":"Hallschmid","year":"2008","journal-title":"Mol. Interventions"},{"key":"10.1016\/j.brainres.2018.08.024_b0185","first-page":"9","article-title":"Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease","author":"Hanson","year":"2008","journal-title":"BMC Neurosci."},{"key":"10.1016\/j.brainres.2018.08.024_b0190","article-title":"The insular cortex dynamically maps changes in cardiorespiratory interoception","author":"Hassanpour","year":"2017","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2018.08.024_b0195","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1460-9568.2008.06029.x","article-title":"Projections from basal forebrain to prefrontal cortex comprise cholinergic, GABAergic and glutamatergic inputs to pyramidal cells or interneurons","volume":"27","author":"Henny","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.brainres.2018.08.024_b0200","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/(SICI)1096-9861(19991213)415:2<145::AID-CNE1>3.0.CO;2-2","article-title":"Hypocretin (orexin) activation and synaptic innervation of the locus coeruleus noradrenergic system","volume":"415","author":"Horvath","year":"1999","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.brainres.2018.08.024_b0205","doi-asserted-by":"crossref","DOI":"10.1126\/science.1255263","article-title":"Fast-spiking, parvalbumin+ GABAergic interneurons: from cellular design to microcircuit function","volume":"345","author":"Hu","year":"2014","journal-title":"Science (80-.)"},{"key":"10.1016\/j.brainres.2018.08.024_b0210","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1152\/jn.00927.2005","article-title":"Prefrontal cortex-projecting glutamatergic thalamic paraventricular nucleus-excited by hypocretin: a feedforward circuit that may enhance cognitive arousal","volume":"95","author":"Huang","year":"2006","journal-title":"J. Neurophysiol."},{"issue":"1\u20137","key":"10.1016\/j.brainres.2018.08.024_b0215","article-title":"Olfactory dysfunction: common in later life and early warning of neurodegenerative disease","volume":"110","author":"H\u00fcttenbrink","year":"2013","journal-title":"Dtsch. Arztebl. Int."},{"key":"10.1016\/j.brainres.2018.08.024_b0220","doi-asserted-by":"crossref","first-page":"5731","DOI":"10.1073\/pnas.1700499114","article-title":"Nonpeptide orexin type-2 receptor agonist ameliorates narcolepsy-cataplexy symptoms in mouse models","volume":"114","author":"Irukayama-Tomobe","year":"2017","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.brainres.2018.08.024_b0225","first-page":"23","article-title":"Systemic administration of hypocretin-1 reduces cataplexy and normalizes sleep and waking durations in narcoleptic dogs","volume":"3","author":"John","year":"2000","journal-title":"Sleep Res. Online"},{"key":"10.1016\/j.brainres.2018.08.024_b0230","first-page":"26","article-title":"Modulation of cortical activation and behavioral arousal by cholinergic and orexinergic systems","volume":"1129","author":"Jones","year":"2008","journal-title":"Mol. Biophys. Mech. Arousal, Alertness, Atten."},{"key":"10.1016\/j.brainres.2018.08.024_b0235","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.bbr.2007.05.033","article-title":"Changes in rat olfactory detection performance induced by orexin and leptin mimicking fasting and satiation","volume":"183","author":"Julliard","year":"2007","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2018.08.024_b0240","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0163-1047(92)90276-A","article-title":"Expression of c-fos and other genes encoding transcription factors in long-term potentiation. [Review]","volume":"57","author":"Kaczmarek","year":"1992","journal-title":"Behav. Neural Biol."},{"key":"10.1016\/j.brainres.2018.08.024_b0245","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1126\/science.1180962","article-title":"Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle","volume":"326","author":"Kang","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.brainres.2018.08.024_b0250","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.neulet.2014.03.020","article-title":"Neuropathological investigation of hypocretin expression in brains of dementia with Lewy bodies","volume":"569","author":"Kasanuki","year":"2014","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2018.08.024_b0255","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0022-3565(24)38126-1","article-title":"Orexin A but not orexin B rapidly enters brain from blood by simple diffusion","volume":"289","author":"Kastin","year":"1999","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.brainres.2018.08.024_b0260","doi-asserted-by":"crossref","unstructured":"Kawaguchi, Y., Kubota, Y., 1997. GABAergic Cell Subtypes and their Synaptic Connections in Rat Frontal Cortex 476\u2013486.","DOI":"10.1093\/cercor\/7.6.476"},{"key":"10.1016\/j.brainres.2018.08.024_b0265","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2045-3701-3-19","article-title":"Development and specification of GABAergic cortical interneurons","volume":"3","author":"Kelsom","year":"2013","journal-title":"Cell Biosci."},{"key":"10.1016\/j.brainres.2018.08.024_b0270","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.neuroscience.2011.01.031","article-title":"Age-related loss of orexin\/hypocretin neurons","volume":"178","author":"Kessler","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2018.08.024_b0275","doi-asserted-by":"crossref","first-page":"3535","DOI":"10.1073\/pnas.1413625112","article-title":"Cortically projecting basal forebrain parvalbumin neurons regulate cortical gamma band oscillations","volume":"112","author":"Kim","year":"2015","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.brainres.2018.08.024_b0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2003.10.003","article-title":"Mechanisms of olfactory dysfunction in aging and neurodegenerative disorders","author":"Kov\u00e1cs","year":"2004","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.brainres.2018.08.024_b0285","doi-asserted-by":"crossref","first-page":"5225","DOI":"10.1523\/JNEUROSCI.0719-05.2005","article-title":"Hypocretin and nicotine excite the same thalamocortical synapses in prefrontal cortex: correlation with improved attention in rat","volume":"25","author":"Lambe","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2018.08.024_b0290","doi-asserted-by":"crossref","DOI":"10.1111\/bph.12296","article-title":"Orexin\/hypocretin receptor signalling: a functional perspective","author":"Leonard","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainres.2018.08.024_b0295","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/bph.12415","article-title":"The hypocretins\/orexins: integrators of multiple physiological functions","volume":"171","author":"Li","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainres.2018.08.024_b0300","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/7854_2016_50","article-title":"Orexin and Alzheimer\u2019s disease","volume":"33","author":"Liguori","year":"2017","journal-title":"Curr. Top. Behav. Neurosci."},{"key":"10.1016\/j.brainres.2018.08.024_b0305","doi-asserted-by":"crossref","first-page":"B54","DOI":"10.1093\/gerona\/51A.1.B54","article-title":"Pathologic characterization of brown Norway, brown Norway x Fischer 344, and Fischer 344 x brown Norway rats with relation to age","volume":"51","author":"Lipman","year":"1996","journal-title":"J. Gerontol. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.brainres.2018.08.024_b0310","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.addr.2011.11.002","article-title":"Intranasal delivery of biologics to the central nervous system","volume":"64","author":"Lochhead","year":"2012","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.brainres.2018.08.024_b0315","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1002\/cne.1190","article-title":"Differential expression of orexin receptors 1 and 2 in the rat brain","volume":"435","author":"Marcus","year":"2001","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.brainres.2018.08.024_b0320","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/cne.23290","article-title":"Distribution and intrinsic membrane properties of basal forebrain GABAergic and parvalbumin neurons in the mouse","volume":"521","author":"Mckenna","year":"2013","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.brainres.2018.08.024_b0325","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1208\/s12248-015-9719-7","article-title":"Intranasal delivery of proteins and peptides in the treatment of neurodegenerative diseases","volume":"17","author":"Meredith","year":"2015","journal-title":"AAPS J."},{"key":"10.1016\/j.brainres.2018.08.024_b0330","doi-asserted-by":"crossref","first-page":"6518","DOI":"10.1523\/JNEUROSCI.6506-10.2011","article-title":"Differential roles of orexin receptor-1 and -2 in the regulation of non-REM and REM sleep","volume":"31","author":"Mieda","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2018.08.024_b0335","doi-asserted-by":"crossref","DOI":"10.1007\/s40263-012-0036-8","article-title":"Orexin (Hypocretin) receptor agonists and antagonists for treatment of sleep disorders: rationale for development and current status","author":"Mieda","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/j.brainres.2018.08.024_b0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.tins.2013.11.004","article-title":"Aging in the olfactory system","author":"Mobley","year":"2014","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.brainres.2018.08.024_b0345","doi-asserted-by":"crossref","first-page":"7931","DOI":"10.1021\/acs.jmedchem.5b00988","article-title":"Design and synthesis of non-peptide, selective orexin receptor 2 agonists","volume":"58","author":"Nagahara","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.brainres.2018.08.024_b0350","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic Clin. Pharm."},{"key":"10.1016\/j.brainres.2018.08.024_b0355","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2869.2006.00533.x","article-title":"Cognitive deficits in narcolepsy","volume":"15","author":"Naumann","year":"2006","journal-title":"J. Sleep Res."},{"key":"10.1016\/j.brainres.2018.08.024_b0360","series-title":"The Rat Brain in Stereotaxic Coordinates","author":"Paxinos","year":"1998"},{"issue":"Pt 3","key":"10.1016\/j.brainres.2018.08.024_b0365","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/brain\/122.3.383","article-title":"Attention and executive deficits in Alzheimer\u2019s disease. A critical review","volume":"122","author":"Perry","year":"1999","journal-title":"Brain"},{"key":"10.1016\/j.brainres.2018.08.024_b0370","doi-asserted-by":"crossref","first-page":"9996","DOI":"10.1523\/JNEUROSCI.18-23-09996.1998","article-title":"Neurons containing hypocretin (orexin) project to multiple neuronal systems","volume":"18","author":"Peyron","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2018.08.024_b0375","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0197-4580(03)00043-5","article-title":"The effect of age on prepro-orexin gene expression and contents of orexin A and B in the rat brain","volume":"25","author":"Porkka-Heiskanen","year":"2004","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2018.08.024_b0380","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.neuroscience.2009.05.043","article-title":"Nutritional status modulates behavioural and olfactory bulb Fos responses to isoamyl acetate or food odour in rats: roles of orexins and leptin","volume":"162","author":"Prud\u2019homme","year":"2009","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2018.08.024_b0385","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neulet.2011.02.055","article-title":"Agonist ligand discrimination by the two orexin receptors depends on the expression system","volume":"494","author":"Putula","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2018.08.024_b0390","first-page":"36","article-title":"Attention deficits in patients with narcolepsy","volume":"26","author":"Rieger","year":"2003","journal-title":"Sleep"},{"key":"10.1016\/j.brainres.2018.08.024_b0395","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1021\/acs.jmedchem.5b00832","article-title":"Orexin receptor antagonists: new therapeutic agents for the treatment of insomnia","volume":"59","author":"Roecker","year":"2016","journal-title":"J. Med. Chem."},{"issue":"Suppl. 2","key":"10.1016\/j.brainres.2018.08.024_b0400","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S1389-9457(02)00156-9","article-title":"Roles of orexins in the regulation of feeding and arousal","volume":"3","author":"Sakurai","year":"2002","journal-title":"Sleep Med."},{"key":"10.1016\/j.brainres.2018.08.024_b0405","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0092-8674(00)80949-6","article-title":"Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior","volume":"92","author":"Sakurai","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.brainres.2018.08.024_b0410","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.neuron.2005.03.010","article-title":"Input of orexin\/hypocretin neurons revealed by a genetically encoded tracer in mice","volume":"46","author":"Sakurai","year":"2005","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2018.08.024_b0415","doi-asserted-by":"crossref","DOI":"10.1159\/000048633","article-title":"Age- and dementia-associated impairments in divided attention: psychological constructs, animal models, and underlying neuronal mechanisms","author":"Sarter","year":"2002","journal-title":"Dement. Geriatr. Cogn. Disord."},{"key":"10.1016\/j.brainres.2018.08.024_b0420","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neulet.2009.10.061","article-title":"Developmental and aging change of orexin-A and -B immunoreactive neurons in the male rat hypothalamus","volume":"468","author":"Sawai","year":"2010","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2018.08.024_b0425","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.neuroscience.2004.05.012","article-title":"Orexins\/hypocretins cause sharp wave- and \u03b8-related synaptic plasticity in the hippocampus via glutamatergic, gabaergic, noradrenergic, and cholinergic signaling","volume":"127","author":"Selbach","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2018.08.024_b0430","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1748-1716.2009.02021.x","article-title":"Orexins\/hypocretins control bistability of hippocampal long-term synaptic plasticity through co-activation of multiple kinases","volume":"198","author":"Selbach","year":"2010","journal-title":"Acta Physiol. (Oxf)"},{"key":"10.1016\/j.brainres.2018.08.024_b0435","doi-asserted-by":"crossref","DOI":"10.1016\/S0092-8674(00)81969-8","article-title":"Narcolepsy: a key role for hypocretins (Orexins)","author":"Siegel","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.brainres.2018.08.024_b0440","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.bmcl.2017.02.012","article-title":"Investigation of orexin-2 selective receptor antagonists: Structural modifications resulting in dual orexin receptor antagonists","volume":"27","author":"Skudlarek","year":"2017","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.brainres.2018.08.024_b0445","doi-asserted-by":"crossref","DOI":"10.1016\/S0163-7258(02)00171-7","article-title":"The physiology and pharmacology of the orexins","author":"Smart","year":"2002","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.brainres.2018.08.024_b0450","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/sj.bjp.0703953","article-title":"SB-334867-A: the first selective orexin-1 receptor antagonist","volume":"132","author":"Smart","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.brainres.2018.08.024_b0455","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nature07991","article-title":"Parvalbumin neurons and gamma rhythms enhance cortical circuit performance","volume":"459","author":"Sohal","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.brainres.2018.08.024_b0460","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2012.43","article-title":"Olfactory discrimination predicts cognitive decline among community-dwelling older adults","volume":"2","author":"Sohrabi","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.brainres.2018.08.024_b0465","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neulet.2006.01.065","article-title":"Modulatory effects of hypocretin-1\/orexin-A with glutamate and gamma-aminobutyric acid on freshly isolated pyramidal neurons from the rat prefrontal cortex","volume":"399","author":"Song","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2018.08.024_b0470","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1021\/acs.molpharmaceut.5b00047","article-title":"Intranasal neuropeptide administration to target the human brain in health and disease","volume":"12","author":"Spetter","year":"2015","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.brainres.2018.08.024_b0475","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.neuroscience.2011.08.033","article-title":"Aging-related alterations in orexin\/hypocretin modulation of septo-hippocampal amino acid neurotransmission","volume":"195","author":"Stanley","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2018.08.024_b0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.neurobiolaging.2010.12.014","article-title":"Interneuron loss reduces dendritic inhibition and GABA release in hippocampus of aged rats","volume":"33","author":"Stanley","year":"2012","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.brainres.2018.08.024_b0485","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/cmdc.201300003","article-title":"Discovery and characterization of ACT-335827, an orally available, brain penetrant orexin receptor type1 selective antagonist","volume":"8","author":"Steiner","year":"2013","journal-title":"ChemMedChem"},{"key":"10.1016\/j.brainres.2018.08.024_b0490","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.neuron.2009.09.005","article-title":"Representations of odor in the piriform cortex","volume":"63","author":"Stettler","year":"2009","journal-title":"Neuron"},{"key":"10.1016\/j.brainres.2018.08.024_b0495","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1080\/13543784.2018.1459561","article-title":"An overview of hypocretin based therapy in narcolepsy","volume":"27","author":"Takenoshita","year":"2018","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.brainres.2018.08.024_b0500","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/S0304-3940(02)00953-9","article-title":"Age-related decline in hypocretin (orexin) receptor 2 messenger RNA levels in the mouse brain","volume":"332","author":"Terao","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.brainres.2018.08.024_b0505","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/sleep\/32.8.993","article-title":"Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy","volume":"32","author":"Thannickal","year":"2009","journal-title":"Sleep"},{"key":"10.1016\/j.brainres.2018.08.024_b0510","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.neuroscience.2004.05.029","article-title":"Delivery of insulin-like growth factor-I to the rat brain and spinal cord along olfactory and trigeminal pathways following intranasal administration","volume":"127","author":"Thorne","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2018.08.024_b0515","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.neuroscience.2008.01.013","article-title":"Delivery of interferon-beta to the monkey nervous system following intranasal administration","volume":"152","author":"Thorne","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.brainres.2018.08.024_b0520","doi-asserted-by":"crossref","DOI":"10.1016\/S0278-5846(97)00077-8","article-title":"The transient 40-Hz response, mismatch negativity, and attentional processes in humans","author":"Tiitinen","year":"1997","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.brainres.2018.08.024_b0525","first-page":"12","article-title":"Orexin receptor agonist Yan 7874 is a weak agonist of orexin\/hypocretin receptors and shows orexin receptor-independent cytotoxicity","author":"Turku","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.brainres.2018.08.024_b0530","doi-asserted-by":"crossref","first-page":"B492","DOI":"10.1093\/gerona\/54.11.B492","article-title":"Growth curves and survival characteristics of the animals used in the biomarkers of aging program","volume":"54","author":"Turturro","year":"1999","journal-title":"J. Gerontol. Ser. A Biol. Sci. Med. Sci."},{"key":"10.1016\/j.brainres.2018.08.024_b0535","doi-asserted-by":"crossref","DOI":"10.3389\/fnbeh.2017.00010","article-title":"Basal forebrain cholinergic system and orexin neurons: effects on attention","volume":"11","author":"Villano","year":"2017","journal-title":"Front. Behav. Neurosci."},{"key":"10.1016\/j.brainres.2018.08.024_b0540","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/sj.npp.1300807","article-title":"Hypocretin\/orexin selectively increases dopamine efflux within the prefrontal cortex: involvement of the ventral tegmental area","volume":"31","author":"Vittoz","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.brainres.2018.08.024_b0545","first-page":"291","article-title":"Improvement of divided attention in narcolepsy by intranasal orexin-A","volume":"23","author":"Weinhold","year":"2014","journal-title":"J. Sleep Res."},{"key":"10.1016\/j.brainres.2018.08.024_b0550","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bbr.2013.12.045","article-title":"The effect of intranasal orexin-A (hypocretin-1) on sleep, wakefulness and attention in narcolepsy with cataplexy","volume":"262","author":"Weinhold","year":"2014","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.brainres.2018.08.024_b0555","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1523\/JNEUROSCI.4622-09.2010","article-title":"Olfactory dysfunction correlates with amyloid-beta burden in an Alzheimer\u2019s disease mouse model","volume":"30","author":"Wesson","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2018.08.024_b0560","doi-asserted-by":"crossref","first-page":"7754","DOI":"10.1523\/JNEUROSCI.22-17-07754.2002","article-title":"Hypocretin increases impulse flow in the septohippocampal GABAergic pathway: implications for arousal via a mechanism of hippocampal disinhibition","volume":"22","author":"Wu","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2018.08.024_b0565","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/cne.22229","article-title":"Immunochemical characterization of inhibitory mouse cortical neurons: three chemically distinct classes of inhibitory cells","volume":"518","author":"Xu","year":"2010","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.brainres.2018.08.024_b0570","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1523\/JNEUROSCI.3235-13.2014","article-title":"Cholinergic neurons excite cortically projecting basal forebrain GABAergic neurons","volume":"34","author":"Yang","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.brainres.2018.08.024_b0575","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/cne.20859","article-title":"Afferents to the orexin neurons of the rat brain","volume":"494","author":"Yoshida","year":"2006","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.brainres.2018.08.024_b0580","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s00213-015-4139-z","article-title":"Orexin A-induced enhancement of attentional processing in rats: role of basal forebrain neurons","volume":"233","author":"Zajo","year":"2016","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.brainres.2018.08.024_b0585","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/S0006-8993(02)02240-0","article-title":"Age-related changes in hypocretin (orexin) immunoreactivity in the cat brainstem","volume":"930","author":"Zhang","year":"2002","journal-title":"Brain Res."}],"container-title":["Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899318304463?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006899318304463?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T17:04:40Z","timestamp":1762103080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006899318304463"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":117,"alternative-id":["S0006899318304463"],"URL":"https:\/\/doi.org\/10.1016\/j.brainres.2018.08.024","relation":{},"ISSN":["0006-8993"],"issn-type":[{"value":"0006-8993","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intranasal administration of orexin peptides: Mechanisms and therapeutic potential for age-related cognitive dysfunction","name":"articletitle","label":"Article Title"},{"value":"Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.brainres.2018.08.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"145921"}}